Jamieson Wellness (TSE:JWEL) was downgraded by stock analysts at Canaccord Genuity from a “buy” rating to a “hold” rating in a research note issued on Thursday. They presently have a C$23.00 target price on the stock, down from their previous target price of C$26.00. Canaccord Genuity’s target price suggests a potential upside of 21.82% from the company’s previous close.
JWEL has been the subject of a number of other research reports. Royal Bank of Canada reduced their price target on Jamieson Wellness from C$29.00 to C$28.00 and set an “outperform” rating for the company in a report on Wednesday, November 7th. BMO Capital Markets cut Jamieson Wellness from an “outperform” rating to a “market perform” rating and reduced their target price for the company from C$28.00 to C$24.00 in a report on Wednesday, November 7th. National Bank Financial reduced their target price on Jamieson Wellness from C$29.00 to C$27.00 and set an “outperform” rating for the company in a report on Wednesday, November 7th. Finally, TD Securities reduced their target price on Jamieson Wellness from C$31.00 to C$27.00 and set a “buy” rating for the company in a report on Friday, November 23rd. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of C$25.60.
Shares of JWEL traded down C$1.83 during mid-day trading on Thursday, reaching C$18.88. The company had a trading volume of 266,176 shares, compared to its average volume of 76,150. Jamieson Wellness has a 52-week low of C$17.15 and a 52-week high of C$27.88. The company has a quick ratio of 0.81, a current ratio of 1.72 and a debt-to-equity ratio of 74.86. The company has a market capitalization of $789.62 million and a price-to-earnings ratio of 36.38.
In related news, insider Christopher Snowden purchased 15,623 shares of the business’s stock in a transaction that occurred on Tuesday, November 13th. The stock was purchased at an average price of C$20.00 per share, with a total value of C$312,460.00. Also, insider Robert Chan sold 2,000 shares of the stock in a transaction that occurred on Friday, December 14th. The shares were sold at an average price of C$21.10, for a total value of C$42,200.00. In the last ninety days, insiders purchased 27,773 shares of company stock valued at $570,593.
Jamieson Wellness Company Profile
Jamieson Wellness Inc develops, manufactures, distributes, sells, and markets natural health products worldwide. The company operates in two segments, Jamieson Brands and Strategic Partners. The company offers health products for humans, including vitamins, herbals, and mineral nutritional supplements; and over-the-counter remedies under the Jamieson and LVHS brands, as well as sports nutrition products under the Progressive, Precision, and Iron Vegan brands.
Recommended Story: What is Compound Annual Growth Rate (CAGR)?
Receive News & Ratings for Jamieson Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jamieson Wellness and related companies with MarketBeat.com's FREE daily email newsletter.